On Dec. 30, 2020, I took the first of two flights to Boston, double-masked and anxious, to roll up my sleeve at Moderna’s manufacturing site just outside the city.
A year earlier, I hadn’t even known the company existed. Now, I was an executive there, part of a team responding to a global catastrophe.Read the rest…